Overall, our results indicate that IFNγ mediates α-syn-mediated neuroinflammation, demyelination, and neurodegeneration in a mouse model of MSA, and thus targeting IFNγ-producing CD4+ T cells is likely to be disease modifying. This evidence concerns the gene CD4 and multiple system atrophy.